Notice of Intent to Publish a Request for Applications for the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) (UH2) (Exploratory/Developmental Cooperative Agreement Phase I)

Notice Number: NOT-AA-16-003

Key Dates
Release Date:  May 9, 2016

Estimated Publication Date of Announcement:  August 2016
First Estimated Application Due Date: November  2016
Earliest Estimated Award Date: April  2017
Earliest Estimated Start Date: June  2017

Related Announcements
RFA-AA-17-012

Issued by
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications from current awardees and new applicants to continue the previously funded “Collaborative Initiative on Fetal Alcohol Spectrum Disorders” (CIFASD). The CIFASD is a multidisciplinary consortium of clinical, basic, and translational research projects established to address the prevention of Fetal Alcohol Spectrum Disorders (FASD), the diagnosis of the full range of birth defects associated with prenatal alcohol exposure, and ameliorative interventions for affected individuals.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

The FOA is expected to be published in the summer of 2016 with an expected application due date in late 2016.

This FOA will utilize the UH2 activity code (Exploratory/Developmental Cooperative Agreement Phase I). Details of the planned FOA are provided below.

Research Initiative Details

This Notice encourages investigators with expertise in Fetal Alcohol Spectrum Disorders research to begin to consider responding to this new FOA.  Projects will represent the developmental/pilot project component of the CIFASD consortium.  This component provides a mechanism for research ideas of a higher-risk/higher-return design and the inclusion of new recruitment sites.   Among the areas of FASD research encouraged in this initiative include (but are not limited to) improved diagnosis, biomarker development, early interventions, and mechanistic studies associated with prenatal alcohol exposure. 


APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Bill Dunty, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-7351
Email: duntyw@mail.nih.gov

Dale Hereld, M.D., Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-0912
Email: hereldd@mail.nih.gov